Virus Diseases
Information
- Disease name
- Virus Diseases
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT05874713 | Active, not recruiting | Phase 2 | Study to Evaluate Safety and Immunogenicity of Different Priming and Booster Regimens With Adjuvanted H5N8 and/or H5N6 Influenza Vaccine in Adults | June 7, 2023 | October 2024 |
| NCT05619770 | Active, not recruiting | Phase 1 | Study to Evaluate Pharmacokinetics, Safety & Tolerability of 101-PGC-005 in Healthy, Adult, Human Subjects | October 29, 2022 | January 15, 2023 |
| NCT05284097 | Active, not recruiting | Phase 2 | Ad26.ZEBOV, MVA-BN-Filo Vaccination in Children and Adults Previously Vaccinated With Control in the EBOVAC-Salone Study | September 19, 2022 | May 31, 2024 |
| NCT04769167 | Active, not recruiting | N/A | Congenital Heart Anomaly Risk in Maternal Enteroviral Infection and Diabetes | February 1, 2021 | December 2027 |
| NCT00343278 | Completed | Phase 4 | Pharmacokinetic Study Of Valaciclovir Hydrochloride Tablets | July 2005 | August 2005 |
| NCT00347672 | Completed | Phase 1 | Safety of and Immune Response to a Bird Flu Virus Vaccine (H5N1) in Healthy Adults | June 2006 | July 2007 |
| NCT00366782 | Completed | Phase 1 | Safety of and Immune Response to a Cow/Human Parainfluenza Virus Vaccine (rB/HPIV3) in Healthy Infants, Children, and Adults | March 2007 | June 2011 |
| NCT00380237 | Completed | Phase 1 | Safety of and Immune Response to a Bird Flu Virus Vaccine (H9N2) in Healthy Adults (Study B) | October 2006 | January 2007 |
| NCT00448604 | Completed | Viral Infections in Chronic Obstructive Pulmonary Disease (COPD) Exacerbations | May 2007 | September 2009 | |
| NCT00488046 | Completed | Phase 1 | Single Group Study of the Safety of and Immune Response to a Bird Flu Virus Vaccine (H5N1) in Healthy Adults | June 2007 | September 2007 |
| NCT00516035 | Completed | Phase 1 | Single Group Study of the Safety of and Immune Response to a Bird Flu Vaccine (H7N3) in Healthy Adults | September 2007 | December 2007 |
| NCT00641017 | Completed | Phase 1 | Safety of and Immune Response to Recombinant Live-Attenuated Parainfluenza Type 1 Virus Vaccine | March 2008 | July 2012 |
| NCT00722774 | Completed | Phase 1 | Safety and Immune Response to Recombinant Live-Attenuated Influenza H2N2 Virus Vaccine | ||
| NCT00734175 | Completed | Phase 1 | Safety of and Immune Response to Recombinant Live-Attenuated Influenza H6N1 Virus Vaccine Vaccine | September 2008 | |
| NCT00749580 | Completed | N/A | A Pilot,Raltegravir Versus NRTIs as a Backbone Switched From a Stable Boosted PI Regimen | November 2008 | July 2011 |
| NCT00853255 | Completed | Phase 1 | Group Study of the Safety of and Immune Response to a Single Dose of Bird Flu Vaccine (H7N3) in Healthy Adults | July 2010 | December 2011 |
| NCT00921726 | Completed | Phase 1 | Pharmacokinetic Study of Oseltamivir and Intravenous Zanamivir in Healthy Adults | July 2009 | October 2009 |
| NCT00921934 | Completed | Intravenous Vitamin C in the Treatment of Viral Infection, Especially in the Treatment of Shingles | April 2009 | December 2010 | |
| NCT00948220 | Completed | Phase 4 | Influence of Antiviral Therapy on Bone Mineral Density and Metabolism in Patients With Chronic Hepatitis C | July 2003 | March 2008 |
| NCT00975572 | Completed | Phase 2 | Novel Influenza A/H1N1 Split- Virion Vaccine in Healthy Population Aged 3 Years and Older | July 2009 | February 2010 |
| NCT00980447 | Completed | Phase 2 | Immunogenicity, Safety and Optimal Dose Finding Study of Recombinant Influenza H5N1 Vaccine in Healthy Young Adults | October 2009 | December 2009 |
| NCT00984945 | Completed | Phase 1 | Safety Study of a Plant-based H5 Virus-Like Particles (VLP) Vaccine in Healthy Adults | September 2009 | July 2010 |
| NCT01021397 | Completed | Phase 1 | Safety of and Immune Response to Recombinant Live Attenuated Parainfluenza Type 3 Virus Vaccine in Healthy Infants and Children | November 2009 | December 2011 |
| NCT01107262 | Completed | Avian Influenza Studies In Lebanon | July 2009 | December 2010 | |
| NCT01163240 | Completed | Epidemiological Study in Children and Adolescents With Chronic Hepatitis B | June 2009 | ||
| NCT01244867 | Completed | Phase 2 | Immunogenicity, Safety, Tolerability of a Plant-Made H5 VLP Influenza Vaccine | November 2010 | September 2011 |
| NCT01337167 | Completed | Phase 3 | Safety, Tolerability, and Immunogenicity of V419 Given Concomitantly With Prevnar 13™ and RotaTeq™ (V419-005) | April 19, 2011 | May 9, 2013 |
| NCT01340937 | Completed | Phase 3 | A Study of V419 Given Concomitantly With Prevnar 13™ and RotaTeq™ (V419-006) | May 10, 2011 | July 26, 2013 |
| NCT01341639 | Completed | Phase 3 | Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 3, 4 and 12 Months (V419-007) | May 26, 2011 | March 13, 2013 |
| NCT01480258 | Completed | Phase 3 | Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 4, and 11 to 12 Months (V419-008) | November 23, 2011 | October 9, 2013 |
| NCT01553279 | Completed | Phase 3 | Immunogenicity and Safety of V419 (PR51) in Combination With MCC in Infants and Toddlers (V419-011) | March 30, 2012 | September 27, 2013 |
| NCT01562444 | Completed | Phase 4 | Study to Evaluate Long Term Immunogenicity up to 10 Years After the First Booster Immunization With Tick Borne Encephalitis Vaccine in Adults Who Received 1 of 3 Different Primary Vaccination Schedules | March 8, 2012 | September 30, 2016 |
| NCT01587131 | Completed | Phase 1 | DNA-based Influenza Vaccine in the Elderly | June 2012 | March 2015 |
| NCT01791556 | Completed | N/A | Clinic-based ART Diagnostic Evaluation | January 26, 2010 | August 2012 |
| NCT01839175 | Completed | Phase 3 | Concomitant Administration of a New Hexavalent Vaccine With a Meningococcal Serogroup C Conjugate Vaccine in Healthy Infants During Primary Series Immunisation Followed by Booster Vaccination | April 2013 | February 2015 |
| NCT01839188 | Completed | Phase 3 | Spanish Mixed HEXA/PENTA/HEXA Schedule (V419-010) | May 1, 2013 | March 19, 2014 |
| NCT01842997 | Completed | Phase 4 | Safety of H1N1 Influenza Vaccination in Pregnant Women | October 2009 | December 2010 |
| NCT01991561 | Completed | Phase 2 | Immunogenicity, Safety, Tolerability of a Plant-made H5 Virus-like-particle (VLP) Influenza Vaccine. | June 2013 | November 2014 |
| NCT01991587 | Completed | Phase 1/Phase 2 | Safety, Tolerability and Immunogenicity of a Plant-made Seasonal Quadrivalent VLP Influenza Vaccine in Adults | October 8, 2013 | June 30, 2014 |
| NCT02012998 | Completed | Phase 3 | Study of the Immunogenicity and Safety of a Challenge Dose of HBVAXPRO in Healthy Children Vaccinated 10 Years Ago With 3 Doses of HEXAVAC or INFANRIX HEXA | January 2014 | February 2015 |
| NCT02022163 | Completed | Phase 1 | Safety, Tolerability and Immunogenicity of a Plant-made H7 Virus-like Particle (VLP) Influenza Vaccine in Adults. | December 2013 | December 2014 |
| NCT02233816 | Completed | Phase 2 | Immunogenicity, Safety and Tolerability of a Plant-Derived Seasonal Virus-Like-Particle Quadrivalent Influenza Vaccine in Adults | July 28, 2014 | June 22, 2015 |
| NCT02236052 | Completed | Phase 2 | Immunogenicity, Safety and Tolerability of a Plant-Derived Seasonal VLP Quadrivalent Influenza Vaccine in the Elderly Population | July 16, 2014 | June 17, 2015 |
| NCT02447705 | Completed | Phase 2/Phase 3 | Replacement of Lamivudine by Telbivudine to Improve Renal Function | June 2013 | January 31, 2017 |
| NCT02469298 | Completed | Phase 2 | Safety, Tolerability and Clinical Effect of Danirixin in Adults With Influenza | June 1, 2015 | April 25, 2016 |
| NCT02485301 | Completed | Phase 2 | A Study to Evaluate the Safety and Immunogenicity of a Candidate Ebola Vaccine in Adults | July 15, 2015 | December 23, 2016 |
| NCT04398004 | Completed | Phase 2 | Anti-inflammatory Clarithromycin for Improving COVID-19 Infection Early | May 6, 2020 | November 30, 2020 |
| NCT00110279 | Completed | Phase 1 | Safety of and Immune Response to a Bird Flu Virus Vaccine (H9N2) in Healthy Adults (Study A) | June 2005 | September 2005 |
| NCT00219453 | Completed | Phase 1 | Pilot Safety Study to Determine the Ability of the Protector Cap Jet Injector to Prevent Cross-Contamination | October 2004 | January 2006 |
| NCT00308412 | Completed | Phase 1 | Safety of and Immune Response to a Human Parainfluenza Virus Vaccine (rHPIV3cp45) in Healthy Infants | June 2006 | April 2010 |
| NCT03294135 | Completed | Phase 4 | The Aim of This Study is to Investigate the Persistence of Antibody Response in Adults up to 15 Years After One Booster Dose of GlaxoSmithKline (GSK) Biologicals' Encepur Adults Vaccine | October 5, 2017 | October 25, 2021 |
| NCT03301051 | Completed | Phase 3 | Efficacy, Safety, and Immunogenicity of a Plant-Derived Quadrivalent Virus-Like Particles (VLPs) Influenza Vaccine in Adults | August 31, 2017 | May 9, 2018 |
| NCT03321968 | Completed | Phase 3 | Lot-to-lot Consistency of a Plant-Derived Quadrivalent Virus-Like Particles Influenza Vaccine in Healthy Adults | September 29, 2017 | December 1, 2017 |
| NCT03392207 | Completed | Active Surveillance for Adverse Events Following Immunization With the Butantan Trivalent Influenza Vaccine (2018) | April 23, 2018 | September 14, 2018 | |
| NCT03487549 | Completed | Phase 2 | Cantharidin and Occlusion in Verruca Epithelium | March 27, 2018 | July 15, 2019 |
| NCT03739112 | Completed | Phase 3 | Efficacy of a Plant-derived Quadrivalent Virus-like Particle (VLP) Vaccine in the Elderly | September 18, 2018 | July 16, 2019 |
| NCT04062669 | Completed | Phase 1 | A Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Experimental Rabies Vaccine in Healthy Adults | August 13, 2019 | July 1, 2022 |
| NCT04074928 | Completed | Phase 3 | Safety and Immunogenicity Study of QIVc in Healthy Pediatric Subjects | September 6, 2019 | September 3, 2020 |
| NCT04339712 | Completed | Phase 2 | Personalised Immunotherapy for SARS-CoV-2 (COVID-19) Associated With Organ Dysfunction | April 2, 2020 | January 8, 2021 |
| NCT04346264 | Completed | CoVid-19 - Infection and Antibody Formation in the Viennese Population | April 27, 2020 | May 27, 2020 | |
| NCT04357366 | Completed | Phase 2 | suPAR-guided Anakinra Treatment for Validation of the Risk and Management of Respiratory Failure by COVID-19 (SAVE) | April 15, 2020 | April 15, 2022 |
| NCT04367740 | Completed | ScreenNC, a Study to Determine the Number of Asymptomatic Individuals Who Have Antibodies to the Virus That Causes COVID-19 | April 28, 2020 | February 28, 2022 | |
| NCT00001164 | Completed | Studies of Patients With Skin Disease, Patients With Neurological Degenerations, and Normal Volunteers | July 1978 | June 2000 | |
| NCT04412551 | Completed | Lung Ultrasound for Assessment of Patients With Moderate to Severe Covid-19 | May 20, 2020 | December 31, 2020 | |
| NCT04414267 | Completed | Phase 4 | Bacillus Calmette-guérin Vaccination to Prevent COVID-19 | May 26, 2020 | May 7, 2021 |
| NCT04441047 | Completed | Phase 1/Phase 2 | Universal Anti-Viral Vaccine for Healthy Elderly Adults | July 12, 2021 | April 1, 2023 |
| NCT04476979 | Completed | Phase 2 | Comparison of Tocilizumab Plus Dexamethasone vs. Dexamethasone for Patients With Covid-19 | July 16, 2020 | August 11, 2021 |
| NCT04644484 | Completed | Phase 3 | A Phase III Clinical Study to Evaluate SYN023's Efficacy and Safety | September 23, 2020 | December 16, 2022 |
| NCT04710199 | Completed | Phase 2 | Trial to Evaluate the Safety and Efficacy of Maraviroc in Patients Hospitalized for Coronavirus Disease 2019 (COVID-19) | February 23, 2021 | July 8, 2021 |
| NCT04758962 | Completed | Phase 1 | A Study of the Safety of and Immune Response to Varying Doses of a Vaccine Against COVID-19 in Healthy Adults | February 15, 2021 | April 19, 2022 |
| NCT04772469 | Completed | N/A | Self-Test Strategies and Linkage Incentives to Improve ART and PrEP Uptake in Men | March 22, 2021 | April 26, 2023 |
| NCT04822818 | Completed | Phase 3 | EFFICACY and SAFETY OF BEVACIZUMAB (ZIRABEV®) IN PATIENTS WITH SEVERE HYPOXEMIC COVID-19 | April 17, 2021 | July 11, 2022 |
| NCT05074953 | Completed | Post-COVID-19 Monitoring in Routine Health Insurance Data | August 1, 2021 | December 31, 2023 | |
| NCT05321433 | Completed | Tobacco Use and the Risk of COVID-19 and Adverse Outcomes | April 1, 2022 | December 31, 2023 | |
| NCT05422326 | Completed | Phase 2 | A Study to Evaluate Safety and Immunogenicity of One or Two Booster Vaccinations With H5N6 Influenza Vaccine in Adults Primed With H5N1 Influenza Vaccine or Unprimed | July 18, 2022 | March 24, 2023 |
| NCT05606198 | Completed | Post-COVID-19 Monitoring in Routine Health Insurance Data With Focus on Autoimmune Diseases (POINTED-AD) | May 1, 2022 | June 19, 2023 | |
| NCT02548078 | Completed | Phase 2 | A Study to Evaluate the Safety and Immunogenicity of a Candidate Ebola Vaccine in Children | November 9, 2015 | May 15, 2017 |
| NCT02630082 | Completed | N/A | Feasibility of Measuring Immune Resp, Activation in Foreskin/Mucosa in HIV-, Uncircumcised High-HIV-risk MSM, Lima Peru | April 2011 | March 2013 |
| NCT02768805 | Completed | Phase 2 | Immunogenicity of a Quadrivalent Virus-Like Particles (VLP) Influenza Vaccine in Healthy Adults | March 2, 2016 | November 26, 2016 |
| NCT02831751 | Completed | Phase 2 | Immunogenicity, Safety, and Tolerability of a Plant-Derived Quadrivalent VLP Influenza Vaccine in Elderly Adults | April 2016 | January 2017 |
| NCT02991872 | Completed | Phase 4 | A Study to Evaluate Persistence of Immune Responses After Post-exposure Prophylaxis of Rabipur® (Purified Chicken-embryo Cell Rabies Vaccine) in Chinese Children | December 16, 2016 | March 12, 2017 |
| NCT03110770 | Completed | Phase 2 | VRC 705: A Zika Virus DNA Vaccine in Healthy Adults and Adolescents | March 29, 2017 | October 4, 2019 |
| NCT03119025 | Completed | Phase 1/Phase 2 | Autologous Dendritic Cell Vaccine for Treatment of Patients With Chronic HCV-Infection | May 2015 | April 2018 |
| NCT04633603 | Enrolling by invitation | LázBarát™ (FeverFriend™) Projekt: Attitude Toward Fever and Its Change in the Healthcare System | January 15, 2020 | December 31, 2023 | |
| NCT05376124 | Recruiting | Clinical Characteristics, Natural Outcome and Treatment Optimization of Refractory | January 1, 2022 | December 31, 2025 | |
| NCT03640728 | Recruiting | The Efficacy and Safety of Nucleos(t)Ide Analogues in the Treatment of HBV-related Acute-on-chronic Liver Failure | January 25, 2019 | July 2023 | |
| NCT04376034 | Recruiting | Phase 3 | Convalescent Plasma Collection and Treatment in Pediatrics and Adults | April 16, 2020 | March 30, 2021 |
| NCT06366672 | Recruiting | Early Phase 1 | Evaluating the Human Immune Response to the JYNNEOS Vaccine | June 10, 2024 | December 2025 |
| NCT06149494 | Recruiting | Phase 2 | RCT of Vapendavir in Patients With COPD and Human Rhinovirus/Enterovirus Upper Respiratory Infection | November 20, 2023 | March 30, 2025 |
| NCT06113757 | Recruiting | N/A | Investigation of Efficacy and Safety of Electrical Signal Therapy Provided by Dr Biolyse® Device in COVID-19 Disease | September 1, 2022 | April 15, 2024 |
| NCT05797246 | Recruiting | Phase 2 | Bevacizumab in Adults With Recurrent Respiratory Papillomatosis (RRP) | August 2, 2023 | November 2, 2026 |
| NCT05875961 | Recruiting | Phase 1 | Study to Evaluate Immunogenicity, Safety and Tolerability of Adjuvanted and Non-Adjuvanted H2N3 Influenza Vaccines in Adults | June 15, 2023 | November 2024 |
| NCT05277285 | Recruiting | Phase 2 | STS Administration on Coronavirus Disease (COVID-19) Patients in Critical Care | April 1, 2022 | December 31, 2023 |
| NCT04124198 | Recruiting | N/A | Quality of Life After Primary TORS vs IMRT for Patients With Early-stage Oropharyngeal Squamous Cell Carcinoma | March 1, 2019 | January 2029 |
| NCT02927431 | Terminated | Phase 2 | Study to Evaluate the Efficacy and Safety of Danirixin Co-administered With Oseltamivir in the Treatment of Adults Hospitalized With Influenza | January 19, 2017 | May 24, 2017 |
| NCT02613403 | Terminated | Phase 2 | Efficacy and Safety of Grazoprevir (+) Uprifosbuvir (+) Ruzasvir (MK-3682B) (MK-5172 + MK-3682 + MK-8408) Fixed Dose Combination in Chronic HCV Participants Failing Prior Antiviral Treatment (MK-3682-021) | December 10, 2015 | March 27, 2017 |
| NCT04322396 | Terminated | Phase 2 | Proactive Protection With Azithromycin and hydroxyChloroquine in Hospitalized Patients With COVID-19 | April 6, 2020 | February 2, 2021 |
| NCT02593851 | Terminated | Phase 1 | A Study to Assess the Pharmacokinetics, Safety, and Tolerability of Multiple Doses of Orally Administered JNJ-53718678 in Infants Hospitalized With Respiratory Syncytial Virus (RSV) Infection | December 4, 2015 | November 10, 2017 |
| NCT01055990 | Unknown status | Phase 2 | Basic and Clinical Research on Applying Blood Fix to Treat Critical H1N1 Patients | October 2009 | May 2010 |
| NCT01289301 | Unknown status | Phase 4 | Studying the Effect of Changing Immunosuppression in Case of Polyoma BK Virus Infection of the Renal Transplant | October 2011 | October 2018 |
| NCT00815464 | Unknown status | N/A | A Single-Arm Study Evaluating the Efficacy of Liquid Acupuncture Therapeutics in Chronic Hepatitis B | March 2009 | March 2010 |
| NCT04380701 | Unknown status | Phase 1/Phase 2 | A Trial Investigating the Safety and Effects of Four BNT162 Vaccines Against COVID-2019 in Healthy and Immunocompromised Adults | April 23, 2020 | April 2023 |
| NCT04382131 | Unknown status | N/A | Hypertonic Saline Nasal Irrigation and Gargling in Suspected or Confirmed COVID-19 (ELVIS COVID-19) | June 23, 2020 | October 31, 2020 |
| NCT04398043 | Unknown status | SARS-CoV 2 in Personal Protective Equipment | May 15, 2020 | July 30, 2020 | |
| NCT03776994 | Unknown status | Phase 1 | Venezuelan Equine Encephalitis Monovalent Virus-Like Particle Vaccine | July 17, 2018 | April 2021 |
| NCT02545517 | Unknown status | Phase 3 | A Clinical Study to Evaluate Immune Responses to Rabies Vaccine in Adults Who Received Different Primary Rabies Vaccination Regimens | October 5, 2015 | November 18, 2022 |
| NCT01062659 | Withdrawn | Cellular Immune Responses in the Liver in Chronic Hepatitis C (CHC) Patients | February 2010 | March 2013 | |
| NCT03192371 | Withdrawn | Phase 4 | A Study to Evaluate the One Year Long-term Persistence of Immune Responses Following Two Different Rabies Vaccine Post-exposure Regimens in Chinese Children | February 15, 2018 | May 12, 2019 |
| NCT04046978 | Withdrawn | N/A | Modelling the Interaction Between Synthetic Model Immunogens and the Induced B and T Cell Repertoires. | December 11, 2019 | December 31, 2022 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D014777